13 nominees · 3 ballot items.
Election of 13 directors; advisory (non-binding) vote to approve named executive officer compensation (say-on-pay); ratification of Ernst & Young LLP as independent registered public accounting firm for 2026; and transacting other business as may properly come before the meeting.
Elect 13 director nominees listed in the proxy statement to serve until the 2027 annual meeting or until successors are elected and qualified.
Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement, including the CD&A and compensation tables.
This management proposal asks shareholders to cast a non-binding advisory vote to approve the Company’s named executive officer compensation as disclosed in the proxy statement. Management (the Talent & Compensation Committee) seeks shareholder approval to validate its compensation framework that ties pay to performance using EPS, free cash flow, PSUs tied to CFVC and ROIC with an RTSR modifier, and a Sustainability and Performance Modifier affecting annual incentives. The Board recommends a vote for the proposal, arguing the program aligns executive incentives with shareholder value, emphasizes long-term performance through PSUs (80% weighting), includes governance safeguards like clawbacks and double-trigger change-in-control protections, and reflects shareholder feedback. The context: Republic delivered strong 2025 financial results, updated PSU metrics and LTI mix in 2025, and received 96.6% support on last year’s say-on-pay — management is using the advisory vote to affirm its approach and maintain engagement with shareholders. The vote is advisory and non-binding; the Committee will review results and consider them when making future compensation decisions.
Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 13,058,206 | $2.9B |
| 2 | STATE STREET CORP | 3.2% | 9,793,456 | $2.1B |
| 3 | BlackRock, Inc. | 2.2% | 6,822,707 | $1.5B |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.0% | 6,016,180 | $1.3B |
| 5 | Capital International Investors | 1.7% | 5,333,574 | $1.2B |
| 6 | BlackRock, Inc. | 1.5% | 4,640,985 | $1.0B |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | 1.4% | 4,316,809 | $945M |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.4% | 4,229,758 | $926M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 4,214,494 | $920M |
| 10 | Pictet Asset Management Holding SA | 1.0% | 3,098,403 | $679M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.